{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,9]],"date-time":"2026-10-09T19:19:34Z","timestamp":1791573574289,"version":"4.3.4"},"reference-count":32,"publisher":"Elsevier BV","issue":"52","license":[{"start":{"date-parts":[[2018,12,1]],"date-time":"2018-12-01T00:00:00Z","timestamp":1543622400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2019,1,29]],"date-time":"2019-01-29T00:00:00Z","timestamp":1548720000000},"content-version":"vor","delay-in-days":59,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["clinicalkey.jp","clinicalkey.com","clinicalkey.es","clinicalkey.fr","clinicalkey.com.au","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Vaccine"],"published-print":{"date-parts":[[2018,12]]},"DOI":"10.1016\/j.vaccine.2018.11.003","type":"journal-article","created":{"date-parts":[[2018,11,8]],"date-time":"2018-11-08T17:45:41Z","timestamp":1541699141000},"page":"7956-7964","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":17,"title":["Spontaneous reports of vaccination errors in the European regulatory database EudraVigilance: A descriptive study"],"prefix":"10.1016","volume":"36","author":[{"given":"Christina E.","family":"Hoeve","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anja","family":"van Haren","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Miriam C.J.M.","family":"Sturkenboom","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sabine M.J.M.","family":"Straus","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.vaccine.2018.11.003_b0005","article-title":"Good practice guide on recording, coding, reporting and assessment of medication errors. EMA\/762563\/2014","author":"Pharmacovigilance Risk Assessment Committee","year":"2015","journal-title":"Eur Med Agency"},{"key":"10.1016\/j.vaccine.2018.11.003_b0010","unstructured":"Directive 2010\/84\/EU of the European Parliament and of the Council of 15 December 2010 amending as regards pharmacovigilance, Directive 2001\/83\/EC on the Community code relating to medicinal products for human use., 2010."},{"key":"10.1016\/j.vaccine.2018.11.003_b0015","unstructured":"Guideline on good pharmacovigilance practices (GVP): Module VI - collection, management and submission of reports of suspected adverse reactions to medicinal products (Rev 2). European Medicines Agency, 2017."},{"issue":"12","key":"10.1016\/j.vaccine.2018.11.003_b0020","doi-asserted-by":"crossref","first-page":"1241","DOI":"10.1007\/s40264-017-0569-3","article-title":"Medication errors: a characterisation of spontaneously reported cases in EudraVigilance","volume":"40","author":"Newbould","year":"2017","journal-title":"Drug Saf"},{"key":"10.1016\/j.vaccine.2018.11.003_b0025","doi-asserted-by":"crossref","first-page":"3049","DOI":"10.1016\/S0264-410X(02)00252-9","article-title":"Medication errors reported to the vaccine adverse event reporting system (VAERS)","volume":"20","author":"Varricchio","year":"2002","journal-title":"Vaccine"},{"issue":"8","key":"10.1016\/j.vaccine.2018.11.003_b0030","doi-asserted-by":"crossref","first-page":"e253","DOI":"10.1097\/INF.0000000000001201","article-title":"Adverse events after MMR or MMRV vaccine in infants under nine months old","volume":"35","author":"Woo","year":"2016","journal-title":"Pediatr Infect Dis J"},{"issue":"16","key":"10.1016\/j.vaccine.2018.11.003_b0035","doi-asserted-by":"crossref","first-page":"1987","DOI":"10.1016\/j.vaccine.2015.01.080","article-title":"Post-licensure surveillance of quadrivalent live attenuated influenza vaccine United States, vaccine adverse event reporting system (VAERS), July 2013-June 2014","volume":"33","author":"Haber","year":"2015","journal-title":"Vaccine"},{"issue":"3","key":"10.1016\/j.vaccine.2018.11.003_b0040","doi-asserted-by":"crossref","first-page":"205","DOI":"10.1093\/jpids\/piu034","article-title":"Post-licensure surveillance of trivalent live-attenuated influenza vaccine in children aged 2\u201318 Years, vaccine adverse event reporting system, United States, July 2005-June 2012","volume":"4","author":"Haber","year":"2015","journal-title":"J Pediat Infect Dis Soc"},{"issue":"48","key":"10.1016\/j.vaccine.2018.11.003_b0045","doi-asserted-by":"crossref","first-page":"6499","DOI":"10.1016\/j.vaccine.2014.09.018","article-title":"Post-licensure surveillance of trivalent live attenuated influenza vaccine in adults, United States, vaccine adverse event reporting system (VAERS), July 2005-June 2013","volume":"32","author":"Haber","year":"2014","journal-title":"Vaccine"},{"issue":"4","key":"10.1016\/j.vaccine.2018.11.003_b0050","doi-asserted-by":"crossref","first-page":"559","DOI":"10.1016\/j.vaccine.2017.11.079","article-title":"Safety of currently licensed hepatitis B surface antigen vaccines in the United States, vaccine adverse event reporting system (VAERS), 2005\u20132015","volume":"36","author":"Haber","year":"2018","journal-title":"Vaccine"},{"issue":"1","key":"10.1016\/j.vaccine.2018.11.003_b0055","doi-asserted-by":"crossref","first-page":"e1","DOI":"10.1097\/INF.0b013e3181ff9795","article-title":"Adverse events following trivalent inactivated influenza vaccination in children: analysis of the vaccine adverse event reporting system","volume":"30","author":"Muhammad","year":"2011","journal-title":"Pediat Infect Dis J"},{"issue":"28","key":"10.1016\/j.vaccine.2018.11.003_b0060","doi-asserted-by":"crossref","first-page":"3171","DOI":"10.1016\/j.vaccine.2015.05.006","article-title":"Vaccination errors reported to the vaccine adverse event reporting system, (VAERS) United States, 2000\u20132013","volume":"33","author":"Hibbs","year":"2015","journal-title":"Vaccine"},{"issue":"35","key":"10.1016\/j.vaccine.2018.11.003_b0065","first-page":"773","article-title":"Notes from the field: reports of expired live attenuated influenza vaccine being administered \u2014 United States, 2007\u20132014","volume":"63","author":"Haber","year":"2014","journal-title":"MMWR"},{"issue":"7","key":"10.1016\/j.vaccine.2018.11.003_b0070","doi-asserted-by":"crossref","first-page":"e016520","DOI":"10.1136\/bmjopen-2017-016520","article-title":"Incidence of live-attenuated influenza vaccine administration beyond expiry date in children and adolescents aged 2\u201317 years in the UK: a population-based cohort study","volume":"7","author":"Caspard","year":"2017","journal-title":"BMJ Open"},{"issue":"4","key":"10.1016\/j.vaccine.2018.11.003_b0075","doi-asserted-by":"crossref","first-page":"218","DOI":"10.1097\/NHH.0000000000000371","article-title":"Administering just the diluent or one of two vaccine components leaves patients unprotected","volume":"34","author":"Shastay","year":"2016","journal-title":"Home Healthcare Now"},{"issue":"65","key":"10.1016\/j.vaccine.2018.11.003_b0080","doi-asserted-by":"crossref","first-page":"161","DOI":"10.15585\/mmwr.mm6506a4","article-title":"Notes from the field: administration error involving a meningococcal conjugate vaccine \u2014 United States, March 1, 2010\u2013September 22, 2015","volume":"19","author":"Su","year":"2016","journal-title":"MMWR Morb Mortal Wkly Rep"},{"issue":"suppl_1","key":"10.1016\/j.vaccine.2018.11.003_b0085","doi-asserted-by":"crossref","first-page":"S152","DOI":"10.1093\/infdis\/jix054","article-title":"Administering multiple injectable vaccines during a single visit-summary of findings from the accelerated introduction of inactivated polio vaccine globally","volume":"216","author":"Dolan","year":"2017","journal-title":"J Infect Dis"},{"key":"10.1016\/j.vaccine.2018.11.003_b0090","unstructured":"Vaccine safety basics \u2013 learning manual. World Health Organization; 2013; Available from: http:\/\/www.who.int\/vaccine_safety\/initiative\/tech_support\/Vaccine-safety-E-course-manual.pdf."},{"key":"10.1016\/j.vaccine.2018.11.003_b0095","unstructured":"Implementation Guide for Electronic Transmission of Individual Case Safety Reports (ICSRs) \u2013 E2B(R3) Data Elements and Message Specification. International Council for Harmonisation of Technical Requirements for Pharmaceuticals for Human Use, 2016."},{"key":"10.1016\/j.vaccine.2018.11.003_b0100","unstructured":"Harmonised Tripartite Guideline: Clinical Safety Data Management: Definitions and Standards for Expedited Reporting E2a. International Conference on Harmonisation of Technical Requirements for Registration of Pharmaceuticals for Human Use, 1994."},{"key":"10.1016\/j.vaccine.2018.11.003_b0105","unstructured":"Inspections and Human Medicines Pharmacovigilance Division. Reporting requirements of Individual Case Safety Reports (ICSRs) applicable to marketing authorisation holders during the interim period, EMA\/411742\/2015 Rev. 9. European Medicines Agency, 2015."},{"key":"10.1016\/j.vaccine.2018.11.003_b0110","unstructured":"German vaccination schedule 2017\/18. Robert Koch Institut; 2017."},{"issue":"7","key":"10.1016\/j.vaccine.2018.11.003_b0115","doi-asserted-by":"crossref","first-page":"629","DOI":"10.1007\/s40264-017-0534-1","article-title":"Patient reporting in the EU: analysis of EudraVigilance data","volume":"40","author":"Banovac","year":"2017","journal-title":"Drug Saf"},{"key":"10.1016\/j.vaccine.2018.11.003_b0120","doi-asserted-by":"crossref","first-page":"24955","DOI":"10.1038\/srep24955","article-title":"Systematic analysis of adverse event reports for sex differences in adverse drug events","volume":"6","author":"Yu","year":"2016","journal-title":"Sci Rep"},{"issue":"8","key":"10.1016\/j.vaccine.2018.11.003_b0125","first-page":"1","article-title":"Chapter 1 gender differences in pharmacological response","volume":"83","author":"Anderson","year":"2008","journal-title":"Int Rev Neurobiol"},{"issue":"7","key":"10.1016\/j.vaccine.2018.11.003_b0130","doi-asserted-by":"crossref","first-page":"460","DOI":"10.1016\/j.cmi.2017.01.012","article-title":"Compliance with vaccination against tick-borne encephalitis virus in Germany","volume":"23","author":"Jacob","year":"2017","journal-title":"Clin Microbiol Inf"},{"key":"10.1016\/j.vaccine.2018.11.003_b0135","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.pvr.2015.10.001","article-title":"HPV vaccine completion and dose adherence among commercially insured females aged 9 through 26 years in the US","volume":"2","author":"Liu","year":"2016","journal-title":"Papillomavirus Res"},{"issue":"35","key":"10.1016\/j.vaccine.2018.11.003_b0140","doi-asserted-by":"crossref","first-page":"5333","DOI":"10.1016\/j.vaccine.2018.05.111","article-title":"Adherence with and completion of recommended hepatitis vaccination schedules among adults in the United States","volume":"36","author":"Trantham","year":"2018","journal-title":"Vaccine"},{"key":"10.1016\/j.vaccine.2018.11.003_b0145","doi-asserted-by":"crossref","first-page":"598","DOI":"10.1186\/1471-2458-13-598","article-title":"Improving immunisation timeliness in aboriginal children through personalised calendars","volume":"13","author":"Abbott","year":"2013","journal-title":"BMC Public Health"},{"issue":"5","key":"10.1016\/j.vaccine.2018.11.003_b0150","doi-asserted-by":"crossref","first-page":"1280","DOI":"10.1080\/21645515.2015.1137404","article-title":"Improving the safety of vaccine delivery","volume":"12","author":"Evans","year":"2016","journal-title":"Human Vac Immunother"},{"key":"10.1016\/j.vaccine.2018.11.003_b0155","unstructured":"Menzies R, McMillan M, Heron L, Lampard J, Joseph T, Chan J, editors. Impact of SMS and calendar reminders on infant immunisation timeliness in Australia. Public health association of Australia communicable diseases control conference; 2017; Melbourne, Australia."},{"key":"10.1016\/j.vaccine.2018.11.003_b0160","unstructured":"Badoo JA. Review and Analysis of Lot Identifier Information Data in the Vaccine Adverse Event Reporting System (VAERS): Master Thesis Presentation, Hood College, Biomedical Science Regulatory Compliance Program; 2012."}],"container-title":["Vaccine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0264410X18315019?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0264410X18315019?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2019,2,19]],"date-time":"2019-02-19T16:47:47Z","timestamp":1550594867000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0264410X18315019"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,12]]},"references-count":32,"journal-issue":{"issue":"52","published-print":{"date-parts":[[2018,12]]}},"alternative-id":["S0264410X18315019"],"URL":"https:\/\/doi.org\/10.1016\/j.vaccine.2018.11.003","relation":{},"ISSN":["0264-410X"],"issn-type":[{"value":"0264-410X","type":"print"}],"subject":[],"published":{"date-parts":[[2018,12]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Spontaneous reports of vaccination errors in the European regulatory database EudraVigilance: A descriptive study","name":"articletitle","label":"Article Title"},{"value":"Vaccine","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.vaccine.2018.11.003","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2019 The Authors. Published by Elsevier Ltd.","name":"copyright","label":"Copyright"}]}}